Related references
Note: Only part of the references are listed.Ovarian Cancer Statistics, 2018
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Circulating tumour cells in prostate cancer
Claudia Hille et al.
NATURE REVIEWS UROLOGY (2018)
Analysis of Circulating Tumor Cells in Ovarian Cancer and Their Clinical Value as a Biomarker
Xuehui Zhang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
The Prognostic Role of Circulating Tumor Cells (CTCs) in Lung Cancer
Joanna Kapeleris et al.
FRONTIERS IN ONCOLOGY (2018)
Pooled Analysis of the Prognostic Relevance of Circulating Tumor Cells in Primary Breast Cancer
Wolfgang J. Janni et al.
CLINICAL CANCER RESEARCH (2016)
Analysis of disseminated tumor cells before and after platinum based chemotherapy in primary ovarian cancer. Do stem cell like cells predict prognosis?
Issam Chebouti et al.
ONCOTARGET (2016)
Circulating Tumor Cells and Response to Chemotherapy in Metastatic Breast Cancer: SWOG S0500
Jeffrey B. Smerage et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Clinical application of circulating tumor cells in breast cancer: overview of the current interventional trials
Francois-Clement Bidard et al.
CANCER AND METASTASIS REVIEWS (2013)
Pooled Analysis of the Prognostic Relevance of Disseminated Tumor Cells in the Bone Marrow of Patients With Ovarian Cancer
Tanja Fehm et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2013)
Platinum-sensitive recurrence in ovarian cancer: the role of tumor microenvironment
Jeremy Chien et al.
FRONTIERS IN ONCOLOGY (2013)
Dormancy in breast cancer
Malgorzata Banys et al.
BREAST CANCER-TARGETS AND THERAPY (2012)
Circulating tumor cells predict progression free survival and overall survival in patients with relapsed/recurrent advanced ovarian cancer
Andres Poveda et al.
GYNECOLOGIC ONCOLOGY (2011)
Molecular Profiling and Prognostic Relevance of Circulating Tumor Cells in the Blood of Ovarian Cancer Patients at Primary Diagnosis and After Platinum-Based Chemotherapy
Bahriye Aktas et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2011)
Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer
S. J. Cohen et al.
ANNALS OF ONCOLOGY (2009)
Clinical significance of circulating tumor cells detected by an invasion assay in peripheral blood of patients with ovarian cancer
Tina Fan et al.
GYNECOLOGIC ONCOLOGY (2009)
Disseminated Tumor Cells in Bone Marrow May Affect Prognosis of Patients With Gynecologic Malignancies
Malgorzata Banys et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2009)
Prognostic impact of KI67, p53, human epithelial growth factor receptor 2, topoisomerase IIα, epidermal growth factor receptor, and nm23 expression of ovarian carcinomas and disseminated tumor cells in the bone marrow
C. Schindlbeck et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2007)
REporting recommendations for tumour MARKer prognostic studies (REMARK)
LM McShane et al.
BRITISH JOURNAL OF CANCER (2005)
Circulating tumor cells: A novel prognostic factor for newly diagnosed metastatic breast cancer
M Cristofanilli et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Circulating tumor cells in the peripheral blood and bone marrow of patients with ovarian carcinoma do not predict prognosis
C Marth et al.
CANCER (2002)
Occult tumor cells in bone marrow of patients with locoregionally restricted ovarian cancer predict early distant metastatic relapse
S Braun et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Share Paper
